Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00620555Phase 3Completed
A Phase 3 trial of gabapentin in focal seizures, sponsored by Viatris. Started May 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00620555.